Nicotinamide: A double edged sword

Parkinsonism and Related Disorders

Volumn 11, Issue 7, 2005, Pages 413-420

  Williams, Adrian ^a   Ramsden, David ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

Malnutrition; Nicotinamide; Pellagra; Protoxins; Tryptophan

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; N METHYLNICOTINAMIDE; NICOTINAMIDE; PYRIDINE; TRYPTOPHAN;

DEGENERATIVE DISEASE; DIET SUPPLEMENTATION; DISEASE ASSOCIATION; FEEDING BEHAVIOR; FOOD INTAKE; FOOD POISONING; HUMAN; INCIDENCE; MALNUTRITION; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOPHYSIOLOGY; PELLAGRA; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; RISK FACTOR;

HUMANS; MPTP POISONING; NIACINAMIDE; PELLAGRA; VITAMIN B COMPLEX;

EID: 27344437464     PISSN: 13538020     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.parkreldis.2005.05.011     Document Type: Review

References (59)

1. E.W. Etheridge The butterfly caste. A social history of pellagra in the South 1972 Greenwood Publishing Westport, CO p. 3-217
2. Goldberger J, Wheeler GA, Sydenestricker E. Pellagra incidence in relation to sex, age, season, occupation, and disabling sickness in seven Cotton-Mill Villages of South Carolina during 1916. Public Health Reports 1920;35:1663.
3. Goldberger J, Waring CH, Willets DG. The treatment and prevention of pellagra. Public Health Reports 1914;29:2821-5.
4. C. Elvehjem, and C.J. Koehn Relation of nicotinic acid and nicotinic acid amide and to canine black tongue J Am Chem Soc 59 1937 1767 1768
5. D.T. Smith, J. Ruffin, and S.G. Smith 'Pellagra successfully treated with nicotinic acid' J Am Med Assoc 109 1993 2054 2055
6. T.D. Spies, C. Cooper, and M.A. Blankenhorn 'The use of nicotinic acid in the treatment of pellagra' JAMA 110 1938 622 627
7. Anon. Aetiology of pellagra and the nutritive value of maize Lancet 1938 282 283
8. Ministry of Food Report of the conference on the post war loaf. Cmd.6701 1945 HMSO London
9. Ministry of Agriculture, Fisheries and Food Food Standards Committee Second report on bread and flour 1974 HMSO London
10. K. Maise, and Z.Z. Chong Nicotinamide: necessary nutrient emerges as a novel cytoprotectant for the brain Trends Pharmacol Sci 24 2003 228 230
11. R. Weinshilboum, D.M. Otterness, and C.L. Szumlanski Methylation pharmacogenetics: catechol O-methyltransferase, thiopurine methyl transferase and histamine N-methyl transferase Annu Rev Pharmacol Toxicol 39 1999 19 52
12. T.A. Alston, and R.H. Abeles Substrate specificity of nicotinamide methyl transferase isolated from porcine liver Arch Biochem Biophys 260 1988 601 608
13. G.C. Davis, A.C. Williams, S.P. Markey, M.H. Ebert, E.D. Caine, C.M. Reichert, and I.J. Kopin Chronic parkinsonism secondary to intravenous injection of meperidine analogues Psychiatr Res 1 1979 249 254
14. J.W. Langston, P. Ballard, J.W. Tetrud, and I. Irwin Chronic parkinsonism in humans due to a product of meperidine-analog synthesis Science 219 1983 979 980
15. S.S. Ansher, J.L. Cadet, W.B. Jakoby, and J.K. Baker Role of N-methyl-transferases in the neurotoxicity associated with the metabolites of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and other 4-substituted pyridines in the environment Biochem Pharmacol 35 1986 3359 3363
16. M.A. Collins, E.J. Neafsey, K. Matsubara, R.J. Cobuzzi, and H. Rollema Indole-N-methylated β-carbolinium ions as potential brain - bioactivated neurotoxins Brain Res 570 1992 154 160
17. T. Nagatasu Isoquinoline neurotoxins in the brain and Parkinson's disease Neurosci Res 29 1997 99 111
18. A. Bedalov, and J.A. Simon NAD to the Rescue Science 305 2004 954 955
19. I. Hervias, B. Lasheras, and N. Aguirre 2-deoxy-d-glusoce prevents and nicotinamide potentiates 3,4-methylenedioxymethamphetamine-induced serotonin neurotoxicity J Neurochem 75 2000 982 990
20. Z.Z. Chong, S.H. Lin, and K. Maiese Nicotinamide modulates mitochondrial membrane potential and cysteine protease activity during cerebral vascular endolethial cell injury J Vasc Res 39 2002 131 147
21. G.J. Hageman, and R.H. Stierum Niacin, poly(ADP-ribose) polymerase-1 and genomic stability Mutat Res 475 2001 45 56
22. S. Green, S. Buttrum, H. Molloy, G. Steventon, S. Sturman, H. Pall, and A. Williams N-methyllation of pyridines in Parkinson's Disease Lancet 338 1991 120 121
23. K. Akoyama, K. Matsubara, K. Okada, S. Fukushima, K. Shimizu, S. Yamaguchi, T. Uezono, M. Satomi, N. Hayase, S. Ohta, H. Shiono, and S. Kobayashi N-methyllation ability for azaheterocyclic amines is higher in Parkinson's disease: nicotinamide loading test J Neural Transm 107 2000 985 995
24. A.J. Bradbury, B. Costa, A.M. Domeney, B. Testa, P.G. Jenner, C.D. Marsden, and R.J. Naylor The toxic actions of MPTP and its metabolite MPP+ are not mimicked by analogues of MPTP lacking the N-methyl moiety Neurosci Lett 61 1985 121 126
25. R. Spector Niacin and niacinamide transport in the central nervous system. In vivo studies J Neurochem 33 1979 895 904
26. R.B. Parsons, M.-L. Smith, A.C. Williams, R.H. Waring, and D.B. Ramsden Expression of nicotinamide N-methyltransferase (E.C. 2.1.1.1) in the Parkinsonian brain J Neuropathol Exp Neurol 61 2002 111 124
27. T. Fukushima, A. Kaetsu, H. Lim, and M. Moriyama Possible role of methylnicotinamide in he pathogenesis of Parkinson's disease Exp Toxic Pathol 53 2002 469 473
28. R.B. Parsons, S.W. Smith, R.H. Waring, A.C. Williams, and D.B. Ramsden High expression of nicotinamide N-methyltransferase in patients with idiopathic Parkinson's disease Neurosci Lett 342 2003 13 16
29. M.F. Beal Bioenergetic approaches for neuroprotection in Parkinson's Disease Ann Neurol 53 suppl 3 2003 39 47
30. A.C. Williams, L.S. Cartwright, and D.B. Ramsden Parkinson's disease: the first common neurological disease due to auto-intoxication? Q J Med 98 2005 215 226
31. J.D. Spillane Nutritional disorders of the nervous system. Chap 2. Pellagra 1947 E&S Livingstone Edinburgh p. 29-47
32. A.Y. Deutch, D.L. osin, M. Goldstein, and R. Roth 3-Acetyl pyridine-induced degeneration of the nigrostriatal dopamine system: an animal model of olivopontocerebellar atrophy-associated parkinsonism Exp Neurol 105 1989 1 12
33. C.G. Charlton, and B. Crowell Jr Striatal dopamine depletion, tremors, and hypokinesia following the intracranial injection of S-adenosylmethionine: a possible role of hypermethylation in Parkinsonism Mol Chem Neuropathol 26 1995 269 283
34. H.N. Vargas, and D.J. Jenden Elevation of cerebrospinal fluid choline levels by nicotinamide involves the enzymatic formation of N-methylnicotinamide in brain tissue Life Sci 58 1996 1995 2002
35. J.K. Blusztajn Choline a vital amine Science 281 1998 794 795
36. J. Willets, J. Lunec, A.C. Williams, and H.R. Griffiths Neurotoxicity of nicotinamide derivatives; their role in the aetiology of Parkinson's disease Biochem Soc Trans 21 1993 299S
37. J. Hardy, M.R. Cookson, and A. Singleton Genes and parkinsonism Lancet Neurol 2 2003 221 228
38. A.C. Williams, H.S. Pall, G.B. Steventon, S. Green, S. Buttrum, H. Molloy, and R.H. Waring N-methyllation of pyridines and Parkinson's disease Adv Neurol 60 1993 194 196
39. A.C. Williams, and R.H. Waring The MPTP tale: pathway to prevention of Parkinson's disease? Br J Hospital Med 49 10 1993 716 719
40. A.C. Williams, M.-L. Smith, R.H. Waring, and D.B. Ramsden The aetiology of idiopathic Parkinson's disease: a genetic and environmental model Adv Neurol 80 1999 215 218
41. Z.-H. Zhang, and G.C. Roman Worldwide occurrence of Parkinson's disease: an updated review Neuroepidemiology 12 1993 195 208
42. Y.S. Wang, Y.M. Shi, Z.Y. Wu, Y.X. He, and B.Z. Zhang Parkinson's disease in China Chin Med J (Engl) 104 1991 960 964
43. N.E. Bharucha, E.P. Bharucha, A.E. Bharucha, A.V. Bhise, and B.S. Shoenberg Prevalence of Parkinson's disease in the Parsi community of Bombay India Arch Neurol 45 1988 1321 1323
44. G.R. Williams, L.T. Kurland, and I.D. Goldberg Morbidity and mortality with Parkinsonism J Neurosurg 24 1966 138 143
45. C.M. Tanner, and Y. Ben-Shlomo Epidemiology of Parkinson's disease Adv Neurol 80 1999 153 159
46. M.D. Benedetti, J.H. Bower, D.M. Maraganore, S.K. McDonnell, B.J. Peterson, J.E. Ahlskog, D.J. Schaid, and W.A. Rocca Smoking, alcohol, and coffee consumption preceding Parkinson's disease: a case-control study Neurology 55 2000 1350 1358
47. G. Logroscino, K. Marder, L. Cote, M.-X. Tang, S. Shea, and R. Mayeux Dietary lipids and antioxidants in Parkinson's disease. A population based case-control study Ann Neurol 39 1996 89 94
48. T.A. Zesiewicz, J.A. Strom, A.R. Borenstein, R.A. Hauser, C.R. Cimino, H.L. Fontanet, G.B. Cintron, J.F. Staffetti, P.B. Dunne, and K. Sullivan Heart failure in Parkinson's disease: analysis of the United States medicare current beneficiary survey Parkinsonism Relat Disorders 10 2004 417 420
49. W.A. Rocca, J.H. Bower, S.K. McDonnell, B.J. Peterson, and D.M. Maraganore Time trends in incidence of Parkinsonism in Olmsted County, Minnesotaa Neurology 57 2001 462 467
50. A. Kuopio, R.J. Marttila, H. Helenius, and U.K. Rinne Changing epidemiology of Parkinson's disease in southwestern Finland Neurology 52 1999 302 308
51. J.M. Gorrell, C.C. Johnson, B.A. Rybicki, E.L. Peterson, and R.J. Richardson The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living Neurology 50 1998 1346 1350
52. D.E. Lilienfeld, E. Chan, J. Ehland, J. Godbold, P.J. Landrigan, G. Marsh, and D.P. Perl Two decades of increasing mortality from Parkinson's Disease amongst the U.S. elderly Arch Neurol 47 1990 731 734
53. D.C. Poskanzer, and R.S. Schwab Cohort analysis of Parkinson's syndrome. Evidence for a single etiology related to subclinical infection about 1920 J Chron Dis 16 1963 961 973
54. R.C. Duvoisin, and M.D. Schweitzer Paralysis Agitans Mortality in England and Wales, 1855-1962 Br J Prev Soc Med 20 1966 27 33
55. L.J. Currie, M.B. Harrison, J.M. Trugman, J.P. Bennett, and F. Wooten Postmenopausal estrogen use affects risk for Parkinson's Disease Arch Neurol 61 2004 886 888
56. W. Hellenbrand, H. Boeing, B.-P. Robra, A. Seidler, P. Vieregge, P. Nischan, J. Joerg, W.H. Oertel, E. Schneider, and G. Ulm Diet and Parkinson's disease. II. Possible role for the past intake of specific nutrients. Results from a self-administered food-frequency questionnaire in a case-control study Neurology 47 1996 644 650
57. G.W. Ross, R.D. Abbott, H. Petrovitch, D.M. Morens, A. Grandinetti, K.H. Tung, C.M. Tanner, K.H. Masaki, P.L. Blanchette, J.D. Curb, J.S. Popper, and L.R. White Association of coffee and caffeine intake with the risk of Parkinson disease JAMA 283 2000 2674 2679
58. K.K. Chen, C.L. Rose, and E.B. Robbins Toxicity of nicotinic acid Prog Soc Exp Biol Med 38 1938 241 245
59. L.T. Kurland, J.F. Kurtzke, I.D. Goldberg, and N.W. Choi Amyotrophic lateral sclerosis and other Motor neurone diseases L.T. Kurland J.F. Kurtzke I.D. Goldberg Epidemiology of neurological and sense organ disorders 1973 Harvard University Press Cambridge, MA 115